SU

Suriakiran Umacanta Sinaikunde

Active Director Director DIN 06960059
DIN 06960059 First appointment Oct 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2014
Shareholding value •••• Premium profile

About Suriakiran Umacanta Sinaikunde

Data last updated:

Suriakiran Umacanta Sinaikunde is a Director at Geno Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Geno Pharmaceuticals Private Limited reported revenue of ₹349 Cr (FY 2025).

DIN 06960059
Primary Designation Director
Industry Pharma
First Appointment 25 Oct 2014
Oldest Company Age 50 yrs
Largest company Geno Pharmaceuticals Private Limited · ₹349 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Geno Pharmaceuticals Private Limited U24239GA1975PTC000250
Director25 Oct 20141975₹349 Cr (FY 2025)Active

Board colleagues of Suriakiran Umacanta Sinaikunde

Directorship timeline

Open interactive timeline →
Geno Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Suriakiran Umacanta Sinaikunde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suriakiran Umacanta Sinaikunde

Suriakiran Umacanta Sinaikunde currently holds 1 directorship: Geno Pharmaceuticals Private Limited (Director, since 25 Oct 2014, revenue ₹349 Cr (FY 2025)).

Suriakiran Umacanta Sinaikunde was first appointed on 25 Oct 2014 as Director at Geno Pharmaceuticals Private Limited.

The current boards of Suriakiran Umacanta Sinaikunde's companies include Dilip Salgaocar Ramacrisna (Geno Pharmaceuticals Private Limited), Pallavi Sagar Salgaocar (Geno Pharmaceuticals Private Limited), Pramod Dilip Salgaocar (Geno Pharmaceuticals Private Limited), Sagar Dilip Salgaocar (Geno Pharmaceuticals Private Limited), Shivam Sagar Salgaocar (Geno Pharmaceuticals Private Limited), Teja Mahesh Gadekar (Geno Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available